Last updated on November 2017

A Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)


Brief description of study

A Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)

Detailed Study Description

The primary objective is to evaluate the efficacy and safety of phosphatidylserine (PS) on cognitive abilities in MCI

Clinical Study Identifier: TX9325

Contact Investigators or Research Sites near you

Start Over

Colleen Figueroa

University of South Florida-Morsani College of Medicine
Tampa, FL USA